JP2024506229A5 - - Google Patents
Info
- Publication number
- JP2024506229A5 JP2024506229A5 JP2023525964A JP2023525964A JP2024506229A5 JP 2024506229 A5 JP2024506229 A5 JP 2024506229A5 JP 2023525964 A JP2023525964 A JP 2023525964A JP 2023525964 A JP2023525964 A JP 2023525964A JP 2024506229 A5 JP2024506229 A5 JP 2024506229A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- levocloperastine
- pharmaceutically acceptable
- acceptable salt
- dizziness
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN202021047025 | 2020-10-28 | ||
| IN202021047025 | 2020-10-28 | ||
| PCT/IN2021/050886 WO2022091118A1 (en) | 2020-10-28 | 2021-09-10 | Anti-vertigo compound and pharmaceutical compositions thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024506229A JP2024506229A (ja) | 2024-02-13 |
| JP2024506229A5 true JP2024506229A5 (enExample) | 2024-09-19 |
| JP7837967B2 JP7837967B2 (ja) | 2026-03-31 |
Family
ID=81382136
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023525964A Active JP7837967B2 (ja) | 2020-10-28 | 2021-09-10 | 抗眩暈組成物及びその医薬組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12685728B2 (enExample) |
| EP (1) | EP4236923A4 (enExample) |
| JP (1) | JP7837967B2 (enExample) |
| CN (1) | CN116963737A (enExample) |
| AU (1) | AU2021368635A1 (enExample) |
| CA (1) | CA3200533A1 (enExample) |
| WO (1) | WO2022091118A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4299059A1 (en) | 2022-07-01 | 2024-01-03 | Labelic Analysis, S.L. | Composition for the treatment of tinnitus |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1228561B (it) | 1989-03-03 | 1991-06-21 | Magis Farmaceutici | Isomero otticamente attivo della cloperastina avente attivita' antitussiva, processo per la sua preparazione e composizioni farmaceutiche che lo contengono. |
| EP0894794A1 (en) * | 1997-07-31 | 1999-02-03 | AESCULAPIUS FARMACEUTICI S.r.l. | Optical isomers of cloperastine |
| JP2004269513A (ja) * | 2003-02-19 | 2004-09-30 | Rohto Pharmaceut Co Ltd | 固形製剤 |
| WO2009089234A2 (en) * | 2008-01-07 | 2009-07-16 | Auspex Pharmaceuticals | Substituted dibenzhydrylpiperazines |
| EA202090172A1 (ru) | 2017-06-29 | 2020-04-21 | Илько Илач Санайи Ве Тиджарет Аноним Ширкети | Суспензия на основе левоклоперастина фендизоата с повышенными растворимостью и ресуспендируемостью |
-
2021
- 2021-09-10 AU AU2021368635A patent/AU2021368635A1/en active Pending
- 2021-09-10 WO PCT/IN2021/050886 patent/WO2022091118A1/en not_active Ceased
- 2021-09-10 CN CN202180074091.1A patent/CN116963737A/zh active Pending
- 2021-09-10 EP EP21885539.3A patent/EP4236923A4/en active Pending
- 2021-09-10 US US18/033,993 patent/US12685728B2/en active Active
- 2021-09-10 JP JP2023525964A patent/JP7837967B2/ja active Active
- 2021-09-10 CA CA3200533A patent/CA3200533A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019306787B2 (en) | Extended release formulations of cannabinoids | |
| JP7378781B2 (ja) | 脳神経の薬理学的な経皮活性化による神経変性障害に関連する症状の治療 | |
| US10071083B2 (en) | Use of gaboxadol in the treatment of tinnitus | |
| US11690849B2 (en) | Method of treating dementia | |
| JP2024123087A (ja) | 改善される運動性及び認知機能のためのアセチル－ロイシン又はその薬学的に許容される塩 | |
| KR20250069704A (ko) | 우울증을 치료하기 위한 nk-1 길항제 조성물 및 우울증 치료에 사용하는 방법 | |
| TW200918042A (en) | 1-amino-alkylcyclohexane derivatives for the treatment of cochlear tinnitus | |
| ES2686529T3 (es) | 6-hidroxibuspirona para su uso en el tratamiento de trastornos del movimiento | |
| CA2667924A1 (en) | The use of pramipexole or a salt thereof for the treatment of parkinson's disease | |
| RU2017112930A (ru) | Офтальмологические составы для доставки лекарств и защиты переднего отдела глаза | |
| JP2012148995A (ja) | 難聴疾患の予防又は治療剤 | |
| JP2015523986A5 (enExample) | ||
| US11744833B2 (en) | Pharmaceutical compositions and methods for treatment of insomnia | |
| CN111093772A (zh) | 偏头痛的治疗 | |
| WO2023158424A1 (en) | Novel pharmaceutical compositions and methods for treatment of insomnia | |
| TW201141468A (en) | Neramexane for the treatment or prevention of inner ear disorders | |
| JP7837967B2 (ja) | 抗眩暈組成物及びその医薬組成物 | |
| UA112652C2 (uk) | Фармацевтична композиція для лікування передчасної еякуляції і спосіб лікування передчасної еякуляції | |
| Roller et al. | Dizziness and vertigo | |
| TWI642431B (zh) | Ｎ－乙醯半胱胺酸用於治療突發性感覺神經性聽力損失的方法 | |
| Kiran et al. | AN OPEN-LABELED, MULTICENTRIC, POST-MARKETING SURVEILLANCE (PMS) TO SUBSTANTIATE THE SAFETY AND EFFICACY OF SINAREST SYRUP IN PATIENTS OF COMMON COLD. | |
| RU2023128802A (ru) | Фармацевтическая композиция, содержащая селективный ингибитор jak3/jak1/tbk1, и ее медицинское применение | |
| RU2438658C2 (ru) | Производные 1-аминоалкилциклогексана для лечения кохлеарного тиннитуса | |
| CN106535883A (zh) | 耳鸣患者的治疗用药剂 | |
| JP2024023688A (ja) | タシメルテオンを用いる障害の治療 |